# Contract Orientation and Kickoff Meeting

> **NIH NIH N01** · UNIVERSITY OF ILLINOIS AT CHICAGO · 2024 · $3,500

## Abstract

The objective of the “Preclinical PREVENT Cancer Program: Toxicology and Pharmacology Testing” IDIQ contracts will be to continue evaluation of the pharmacological and toxicological effects of potential cancer preventative agents. Resources from these contracts will be used to support development of several candidate cancer preventive agents.

## Key facts

- **NIH application ID:** 11032070
- **Project number:** 75N91024D00002-0-759102400001-1
- **Recipient organization:** UNIVERSITY OF ILLINOIS AT CHICAGO
- **Principal Investigator:** ALEXANDER V LYUBIMOV
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,500
- **Award type:** —
- **Project period:** 2024-01-25 → 2029-02-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11032070

## Citation

> US National Institutes of Health, RePORTER application 11032070, Contract Orientation and Kickoff Meeting (75N91024D00002-0-759102400001-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11032070. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*